EU regulation sets out uniform conditions for various pharmacovigilance activities
This article was originally published in Scrip
Executive Summary
The European Commission has published a draft regulation specifying how certain activities under the EU pharmacovigilance framework should be performed by marketing authorisation holders, national competent authorities and the European Medicines Agency.